Kallan F V, Brandt C J, Ellegaard H, Joensen M B, Sorknaes A D, Tougaard L
Medicinsk afdeling, Sygehus Fyn, Faaborg.
Ugeskr Laeger. 1997 Oct 27;159(44):6528-30.
In a controlled randomised trial we analysed whether the use of the term "smoker's lung" (Danish: "rygerlunger") instead of chronic bronchitis when talking to patients with chronic obstructive lung disease (COLD) changed their smoking habits. Fifty-six smoking patients with COLD were allocated to either intervention (n = 25) or control groups (n = 31). In the intervention group the lung disease was designated smoker's lung in all communication with patients about their illness and in the control group traditional terminology was used. All patients were given the same medical treatment and the same encouragement to stop smoking. One week after discharge 57% had stopped smoking in the smoker's lung group vs 26% in the control group (p = 0.028), at three months 50% vs 19% (p = 0.027) and at one year 40% vs 20% (p = 0.148). Referring directly to the cause of a self-inflicted illness may be an effective way of discouraging risk behaviour, at negligible cost.
在一项对照随机试验中，我们分析了在与慢性阻塞性肺病（COLD）患者交谈时，使用“吸烟者的肺”（丹麦语：“rygerlunger”）而非慢性支气管炎这一术语是否会改变他们的吸烟习惯。56名吸烟的COLD患者被分配到干预组（n = 25）或对照组（n = 31）。在干预组中，在与患者交流其病情时，将肺部疾病称为吸烟者的肺，而在对照组中使用传统术语。所有患者都接受相同的药物治疗和相同的戒烟鼓励。出院一周后，吸烟者的肺组中有57%的人戒烟，而对照组为26%（p = 0.028）；三个月时，分别为50%和19%（p = 0.027）；一年时，分别为40%和20%（p = 0.148）。直接提及自身造成疾病的原因可能是一种以可忽略不计的成本劝阻风险行为的有效方式。
